BioCentury
ARTICLE | Company News

FDA to review ragweed allergy tablet

May 9, 2013 1:10 AM UTC

Merck & Co. Inc. (NYSE:MRK) said FDA accepted for review a BLA for Ragweed Allergy Immunotherapy Tablet (AIT) in adults with ragweed-induced allergic rhinitis. The pharma submitted the BLA in March an...